ClinicalTrials.Veeva

Menu

Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer (SALSA)

Fred Hutchinson Cancer Center (FHCC) logo

Fred Hutchinson Cancer Center (FHCC)

Status

Active, not recruiting

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Treatments

Other: Survey Administration
Behavioral: Behavioral Intervention
Other: Interview

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05075759
10784
R01CA263144 (U.S. NIH Grant/Contract)
RG1121690 (Other Identifier)
NCI-2021-09186 (Registry Identifier)

Details and patient eligibility

About

This clinical trial evaluates several behavioral interventions for the improvement of physical activity in cancer patients. Childhood and adolescent/young adult cancer survivors have been reported to have poor diet quality and rarely meet recommended physical activity guidelines. This trial aims to see whether a tailored intervention based on self-determination theory may help to improve physical activity and dietary change.

Full description

OUTLINE: Patients are randomized to Arms 1, 2, or 3.

ARM 1: Patients receive a personalized clinician-led self-management telehealth session at baseline and 2 months. Patients with poor response at 3 months are randomized to Arm 2 or 4, otherwise patients receive the same telehealth session at months 4 and 6. Patients may receive 2 additional telehealth sessions after 6 months.

ARM 2: Patients receive personalized goal setting for daily steps and activity (updated weekly) and 3 dietary goals (updated monthly) with social media peer support for 6 months. Patients with poor response at 3 months are randomized to Arms 1 or 4. Patients may receive personalized goal setting for daily steps and activity (updated monthly) and dietary goals (updated every 2 months) after 6 months.

ARM 3: Patients receive no intervention for 12 months. After 12 months, they may optionally receive their choice of intervention for up to 6 months.

ARM 4: If Arms 1 or 2 patients have poor response after 3 months, patients may be re-randomized to Arm 4. Patients receive remote sessions with a health coach every 1-2 weeks for 3 months. Patients may continue to receive remote sessions once a month after 3 months, during the maintenance phase (months 6-12).

Enrollment

374 patients

Sex

All

Ages

18 to 54 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Childhood Cancer Survivor Study (CCSS) participant who is between age 18 to < 55 years at time of initial approach

  • Moderate to high CV risk status based on CCSS risk prediction models for cardiomyopathy and ischemic heart disease

  • Able to read, write, and speak English

  • Ability to understand and the willingness to provide informed consent

  • At least one of the following:

    • Less than 30 minutes/day of moderate to vigorous physical activity (MVPA) based on validated self-report instrument (Godin)
    • Healthy Eating Index (HEI)-2015 score < 60 per study food frequency questionnaire (FFQ)
    • Body mass index (BMI) >= 25 kg/m^2 per self-reported height and weight
  • Be free of any known (self-reported) ischemic heart disease or cardiomyopathy

  • Have internet access (can be via smartphone or computer; if neither device is available, the study can loan participants a Wi-Fi enabled device, but participant will need to have access to the internet)

Exclusion criteria

  • Individuals with known cardiomyopathy or ischemic heart disease based on prior CCSS surveys are excluded. While not likely to be common, participants who newly report in our study's screening questionnaire that they have newly diagnosed cardiomyopathy or ischemic heart disease will also be excluded
  • Having any self-reported contraindication to walking or being physically active
  • Not currently known to be pregnant; individuals known to be pregnant and otherwise eligible for the study can be enrolled once no longer known to be pregnant. Participants who report being pregnant after randomization can remain in the study
  • Individuals receiving active cancer treatment. Participants who report starting active cancer treatment after randomization can remain in the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

374 participants in 4 patient groups

Arm 1 (personalized clinician-led self-management telehealth)
Experimental group
Description:
Patients receive a personalized clinician-led self-management telehealth session at baseline and 2 months. Patients with poor response at 3 months are randomized to Arm 2 or 4, otherwise patients receive the same telehealth session at months 4 and 6. Patients may receive 2 additional telehealth sessions after 6 months.
Treatment:
Other: Interview
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Other: Survey Administration
Arm 2 (personalized goal setting)
Experimental group
Description:
Patients receive personalized goal setting for daily steps and activity (updated weekly) and 3 dietary goals (updated monthly) with social media peer support for 6 months. Patients with poor response at 3 months are randomized to Arms 1 or 4. Patients may receive personalized goal setting for daily steps and activity (updated monthly) and dietary goals (updated monthly) after 6 months.
Treatment:
Other: Interview
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Other: Survey Administration
Arm 3 (waitlist)
Active Comparator group
Description:
Patients receive no intervention for 12 months. After 12 months, they may optionally receive their choice of intervention for up to 6 months.
Treatment:
Other: Interview
Other: Survey Administration
Arm 4 (remote sessions with a health coach)
Experimental group
Description:
Arm 1 and 2 patients with poor response after 3 months can be re-randomized to Arm 4. Patients receive remote sessions with a health coach every 1-2 weeks for 3 months. Patients may continue to receive remote sessions once a month after 3 months, during the maintenance phase (months 6-12).
Treatment:
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Behavioral: Behavioral Intervention
Other: Survey Administration

Trial documents
1

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems